Lorbrena Tablet, Film Coated
Product Images NDC 0069-0227

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lorbrena (NDC 0069-0227). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lorbrena 01)

Chemical structure of lorlatinib, the active ingredient in Lorbrena. The diagram shows the molecular arrangement including key functional groups and ring structures characteristic of lorlatinib.*

FDA Label Image

Figure 1 (Lorbrena 02)

A Kaplan-Meier curve chart showing progression-free survival probability (%) over time in months comparing Lorbrena (lorlatinib) and Crizotinib. The solid line represents Lorbrena with a median not reached, while the dotted line represents Crizotinib with a median survival of 9.3 months. The chart includes a hazard ratio of 0.28 with 95% confidence interval (0.19, 0.41) and p-value <0.0001, plus a table of numbers at risk for both drugs over the study duration up to 33 months.*

FDA Label Image

Logo (Lorbrena 03)

FDA Label Image

Logo (Lorbrena 04)

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Label for Lorbrena (lorlatinib) film-coated tablets, 25 mg strength, manufactured by Pfizer Laboratories Div Pfizer Inc. The label indicates a package of 30 tablets, with storage instructions and a caution to dispense in child-resistant containers. The label includes barcode, NDC 0069-0227-01, and storage temperature details.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

The label for Lorbrena 100 mg (lorlatinib) tablets by Pfizer Laboratories. It features storage instructions, dosage use note, and states each tablet contains 100 mg lorlatinib. The package contains 30 film-coated oral tablets. The label includes barcodes and identifies Pfizer as the distributor.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.